Intuitive Surgical, Inc. $ISRG Shares Acquired by Vise Technologies Inc.

Key Points

• Vise Technologies increased its Intuitive Surgical stake by 43.7% in the third quarter, bringing its holdings to 20,025 shares valued at approximately $8.14 million. Institutional investors collectively own 83.64% of the company.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $493.54; several firms recently raised their targets, including Robert W. Baird to $550.
• Intuitive Surgical exceeded quarterly expectations, reporting $3.00 in EPS on $3.05 billion in revenue, with revenue rising 21.7% year over year. Meanwhile, insiders sold 38,778 shares worth $16.8 million over the past three months.

Vise Technologies Inc. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 43.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,025 shares of the medical equipment provider's stock after buying an additional 6,087 shares during the period. Vise Technologies Inc.'s holdings in Intuitive Surgical were worth $8,143,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. Bank of America Corp DE grew its stake in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock worth $1,667,388,000 after acquiring an additional 116,292 shares during the period. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth $1,335,753,000. Amundi boosted its holdings in shares of Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its holdings in shares of Intuitive Surgical by 3.7% during the first quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider's stock worth $757,489,000 after purchasing an additional 58,587 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 20,095 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the sale, the director directly owned 1,204,530 shares in the company, valued at $543,977,793.30. The trade was a 1.64% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of the company's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the sale, the director directly owned 251 shares in the company, valued at $95,129. This represents a 61.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 38,778 shares of company stock worth $16,814,967 over the last three months. Insiders own 0.60% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on ISRG shares. Barclays reiterated an "overweight" rating and issued a $500.00 target price (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday, October 21st. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $450.00 to $475.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 21st. Raymond James Financial restated an "outperform" rating and issued a $480.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Robert W. Baird lifted their price target on Intuitive Surgical from $513.00 to $550.00 and gave the company an "outperform" rating in a report on Wednesday, October 21st. Finally, BMO Capital Markets reaffirmed an "outperform" rating on shares of Intuitive Surgical in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $493.54.

Intuitive Surgical Stock Up 1.1%

Shares of NASDAQ ISRG opened at $436.87 on Tuesday. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The firm has a fifty day moving average of $402.70 and a 200-day moving average of $433.43. The stock has a market capitalization of $151.44 billion, a PE ratio of 52.83, a P/E/G ratio of 3.06 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The business had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same period last year, the company posted $2.40 EPS. The business's quarterly revenue was up 21.7% on a year-over-year basis. Equities research analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.